Related Experiment Video
Updated: Dec 27, 2025
09:51
Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
Published on: March 3, 2020
9.6K
Dexamethasone Loaded Liposomes by Thin-Film Hydration and Microfluidic Procedures: Formulation Challenges
M D Al-Amin1, Federica Bellato1, Francesca Mastrotto1
1Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via F. Marzolo 5, 35131 Padova, Italy.
International Journal of Molecular Sciences
|March 1, 2020
Summary
Microfluidic techniques enable scalable liposome production with improved drug loading and efficiency compared to traditional methods. This advanced approach enhances liposomal formulations for controlled drug release and clinical applications.
Area of Science:
- Pharmaceutical Sciences
- Biotechnology
- Materials Science
Background:
- Liposomes are widely used drug delivery systems, but challenges in large-scale production hinder clinical translation.
- Optimizing formulation parameters is crucial for consistent liposome properties and therapeutic efficacy.
Purpose of the Study:
- To compare liposomes produced via thin-film hydration and microfluidics for drug delivery applications.
- To evaluate the impact of formulation methods on liposome characteristics, drug loading, and release profiles.
- To assess the in vitro performance and scalability of microfluidic-generated liposomes.
Main Methods:
- Liposomes were prepared using thin-film hydration and microfluidic techniques.
- Dexamethasone hemisuccinate was remotely loaded into liposomes using a calcium acetate gradient.
- Colloidal properties, drug loading capacity/efficiency, in vitro drug release, and cellular interactions were analyzed.
Main Results:
- Microfluidic liposomes exhibited a unilamellar structure, while thin-film hydration produced multilamellar liposomes.
- Microfluidic methods resulted in higher drug loading capacity and efficiency with reduced batch-to-batch variability.
- Both formulations showed sustained drug release over one month; microfluidic liposomes demonstrated slightly faster initial release.
- In vitro studies confirmed non-toxicity, cellular association with ARPE-19 cells, and effective inflammation reduction, with microfluidic liposomes showing a slight advantage.
Conclusions:
- Microfluidic techniques offer a scalable and advantageous method for producing liposomes with enhanced biopharmaceutical properties.
- This approach facilitates the development of improved liposomal drug-controlled release formulations for clinical applications.
- Microfluidics addresses key challenges in liposome manufacturing, paving the way for more efficient drug delivery systems.
